408 related articles for article (PubMed ID: 26811609)
1. Insight to drug delivery aspects for colorectal cancer.
Gulbake A; Jain A; Jain A; Jain A; Jain SK
World J Gastroenterol; 2016 Jan; 22(2):582-99. PubMed ID: 26811609
[TBL] [Abstract][Full Text] [Related]
2. Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer.
Krishnaiah YS; Khan MA
Pharm Dev Technol; 2012; 17(5):521-40. PubMed ID: 22681390
[TBL] [Abstract][Full Text] [Related]
3. Getting into the colon: approaches to target colorectal cancer.
Patel MM
Expert Opin Drug Deliv; 2014 Sep; 11(9):1343-50. PubMed ID: 24898947
[TBL] [Abstract][Full Text] [Related]
4. Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer.
Grifantini R; Taranta M; Gherardini L; Naldi I; Parri M; Grandi A; Giannetti A; Tombelli S; Lucarini G; Ricotti L; Campagnoli S; De Camilli E; Pelosi G; Baldini F; Menciassi A; Viale G; Pileri P; Cinti C
J Control Release; 2018 Jun; 280():76-86. PubMed ID: 29733876
[TBL] [Abstract][Full Text] [Related]
5. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
[TBL] [Abstract][Full Text] [Related]
6. Exploring Different Strategies for Efficient Delivery of Colorectal Cancer Therapy.
Lin C; Ng HL; Pan W; Chen H; Zhang G; Bian Z; Lu A; Yang Z
Int J Mol Sci; 2015 Nov; 16(11):26936-52. PubMed ID: 26569228
[TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
8. New Trends in Liposome-based Drug Delivery in Colorectal Cancer.
Krajewska JB; Bartoszek A; Fichna J
Mini Rev Med Chem; 2019; 19(1):3-11. PubMed ID: 30179131
[TBL] [Abstract][Full Text] [Related]
9. Basics to advances in nanotherapy of colorectal cancer.
Tiwari A; Saraf S; Jain A; Panda PK; Verma A; Jain SK
Drug Deliv Transl Res; 2020 Apr; 10(2):319-338. PubMed ID: 31701486
[TBL] [Abstract][Full Text] [Related]
10. Colon cancer targeting using conjugates biomaterial 5-flurouracil.
Jaferian S; Negahdari B; Eatemadi A
Biomed Pharmacother; 2016 Dec; 84():780-788. PubMed ID: 27721176
[TBL] [Abstract][Full Text] [Related]
11. Novel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived.
O'Neil BH; Goldberg RM
Expert Opin Investig Drugs; 2003 Dec; 12(12):1939-49. PubMed ID: 14640938
[TBL] [Abstract][Full Text] [Related]
12. Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer.
Adams R; Maughan T
Expert Rev Anticancer Ther; 2007 Apr; 7(4):503-18. PubMed ID: 17428171
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer management: strategies in drug delivery.
Singh P; Waghambare P; Khan TA; Omri A
Expert Opin Drug Deliv; 2022 Jun; 19(6):653-670. PubMed ID: 35656670
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in antibody derivatives against colorectal cancer; A review.
Ghani S; Bahrami S; Rafiee B; Eyvazi S; Yarian F; Ahangarzadeh S; Khalili S; Shahzamani K; Jafarisani M; Bandehpour M; Kazemi B
Life Sci; 2021 Jan; 265():118791. PubMed ID: 33220288
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone hydrochloride: chemopreventive potential and development of site-specific drug delivery systems.
Sinha VR; Sethi S
Drug Deliv; 2015 May; 22(3):408-17. PubMed ID: 24547712
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer.
Marin JJ; Sanchez de Medina F; Castaño B; Bujanda L; Romero MR; Martinez-Augustin O; Moral-Avila RD; Briz O
Drug Metab Rev; 2012 May; 44(2):148-72. PubMed ID: 22497631
[TBL] [Abstract][Full Text] [Related]
18. Orally delivered targeted nanotherapeutics for the treatment of colorectal cancer.
Zhang X; Song H; Canup BSB; Xiao B
Expert Opin Drug Deliv; 2020 Jun; 17(6):781-790. PubMed ID: 32237921
[TBL] [Abstract][Full Text] [Related]
19. The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery.
Ma Y; Fuchs AV; Boase NR; Rolfe BE; Coombes AG; Thurecht KJ
Eur J Pharm Biopharm; 2015 Aug; 94():393-403. PubMed ID: 26117186
[TBL] [Abstract][Full Text] [Related]
20. Conjugation Strategies for Colonic Delivery and its Application in Colorectal Cancer Therapy.
Tran PHL; Duan W; Tran TTD
Curr Drug Metab; 2017; 18(11):1016-1019. PubMed ID: 29086687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
